Pathologically, NCS-1/InsP3R1 interaction is believed to be involved in bipolar disorder (Schlecker et al., 2006) because lithium, a medical drug for bipolar disorder, inhibited the NCS-1-induced enhancement of InsP3R function. Here, ITPR1 is linked to bipolar disorder.